LISA MCDANIEL: Open Payments
NPI 1932647450 · OTTAWA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,311 in 127 payments from 17 companies in 2025. Trend: 2023 $783 · 2024 $912 · 2025 $2,311
Food & beverage: $2,075Education: $236
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $594 |
| ABBVIE INC. | 25 | $333 |
| UCB, Inc. | 19 | $270 |
| Lilly USA, LLC | 16 | $220 |
| E.R. Squibb & Sons, L.L.C. | 9 | $189 |
| Amgen Inc. | 6 | $150 |
| Regeneron Healthcare Solutions, Inc. | 4 | $143 |
| LEO Pharma Inc. | 5 | $87 |
| GENZYME CORPORATION | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
Products named: TREMFYA, Bimzelx, TALTZ, DUPIXENT, SKYRIZI, Sotyktu, RINVOQ, ADBRY.
Industry payments across KS — which companies pay providers there.
